Atlas Trials

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Clinical trial NCT06061640 · UNKNOWN

Trial details

NCT number
NCT06061640
Sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Metabolic Dysfunction-associated Fatty Liver Disease
Start date
2023-06-01
Primary completion
2024-06-30
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.